Their study on radical tonsillectomy inspired further research in the field and, finally, in 2009, TORS received Food and Drug Administration (FDA) approval for resections of T1–T2 malignancies of the oral cavity, pharynx, and larynx, as well as benign lesions. In 2007, the concept of transoral robotic surgery (TORS) was introduced by Weinstein et al. This technology offers better surgical comfort in remote-access areas due to the presence of wristed instruments with seven degrees of freedom. Robotic surgery using the Da Vinci ® surgical system gained popularity in the early 2000s in the fields of urology and gynecology thanks to its magnified three-dimensional vision, absence of surgeon tremor, and higher precision.
0 Comments
Leave a Reply. |